Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in mild to moderate COVID-19 outpatients (ACTIV-6)
NCT05894577Phase 3Completed
- Start
- Jan 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast in coronavirus disease 2019 (COVID-19). Started Jan 2023; status: completed.
02
Drugs
montelukast
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05894577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05894577.